Three weeks ago, European polypropylene prices jumped EUR 220 per tonne. In a single move. Propylene feedstock spot prices surged EUR 200 per tonne in one week. The Strait of Hormuz effectively closed to container traffic. Middle Eastern suppliers, who had been the dominant source for European and African markets, withdrew their offers within days. 1,2
None of this was secret. Commodity desks saw it. Logistics teams flagged it. The data was there.
And yet, across hundreds of European pharmaceutical and chemical companies, a procurement decision worth seven figures sat unmade. Not because the information was missing, but because no process existed to surface it, structure it, and force a choice.
The decision that procurement teams are facing right now
If you run packaging procurement at a mid-sized European pharma company, you do not buy polypropylene directly. Your tier 1 packaging supplier does. They convert it into blister packs, bottles, closures, and films. You buy the finished packaging.
But when PP prices move by 22% in three weeks 1, that shock travels through your supply chain. Your supplier absorbs it for a while. Then they send a price increase letter. By the time it reaches your desk, the new baseline is established. The negotiation is about how much of the increase you accept, not whether you could have avoided it.
For a company spending EUR 20 million per year on packaging, with roughly 30-50% of that cost exposed to polymer content (depending on the mix of blisters, bottles, and closures), the PP price spike represents a potential EUR 1.3 million to EUR 2.2 million annual cost increase at current spot levels. That number will change. It might moderate. It might worsen. But right now, it is real, and it is sitting on somebody’s desk as an unsigned price increase letter.
The question is not whether procurement teams know about this. They do. The question is what they are doing about it, and when they started.
Four options. One is the default. Three require a decision.
When a tier 2 commodity shock hits your packaging supply chain, there are four responses available. They are not equally visible to most organisations.
Accept the pass-through. Wait for your packaging supplier to send a revised price schedule. Review it. Negotiate the margin. Accept some version of the increase. This is the path of least organisational resistance. It requires no cross-functional coordination, no advance analysis, and no proactive conversation with suppliers. It is also, reliably, the most expensive option.
Renegotiate with commodity indexing. Approach your tier 1 packaging supplier now, before the price increase letter arrives, and renegotiate the contract with a clause that ties packaging prices to a published polymer index. This converts a fixed-price exposure into a variable one that moves with the market in both directions. The conversation is harder. It requires understanding your own cost structure well enough to know what percentage of your packaging spend is polymer-exposed. But it fundamentally changes the economics.
Direct your supplier to lock in volumes. Instruct your packaging supplier to forward-purchase PP at current prices, with an agreed cost-sharing mechanism for the premium. This requires a different kind of relationship with your supplier and a clear view of your own volume commitments. Few companies have the procurement architecture to execute this quickly.
Qualify alternatives. Begin qualification of alternative packaging materials or suppliers from regions less exposed to the current disruption. In pharma, this is an 18-to-24-month process depending on the regulatory pathway, potentially longer for products requiring stability data or variation filings. If you are not already in motion, this option is unavailable for the current cycle. But if you started a year ago, you would have a structural hedge today that no contract renegotiation can match.
Some analysts had flagged the Strait of Hormuz risk as early as late February 5, before the full disruption materialised. The signal existed. The question is whether any procurement process was designed to act on it.
What inaction actually costs
Let us make this concrete with two of those four options.
Option 1: Accept the pass-through
Your packaging supplier absorbs the first four to six weeks of the commodity shock. They have hedged inventory and contractual buffers. Then the letter arrives. At that point, the market has established the new price as normal. Your negotiation starts from the new baseline.
On EUR 8 million of polymer-exposed packaging spend (using 40% as a mid-range estimate), a 22% commodity increase that flows through at varying rates depending on contract structure, typically 50-80% over a twelve-month period, represents close to a million euros in annualised additional cost, often more. That is the number you negotiate against. You might reduce it by 10-15% through hard negotiation. You are still paying the bulk of it.
Option 2: Renegotiate with commodity indexing
If you had approached your supplier in the first week of March, before the full price move, you could have negotiated an index-linked clause tied to the ICIS European PP contract price. At that point, the propylene contract had settled at EUR 1,000 per tonne for March, up from EUR 965 in February 2. A meaningful move, but not yet the EUR 200 per tonne spot spike that followed.
The value of this conversation is not in avoiding the increase entirely. It is in changing the mechanism. An index-linked contract means you pay the market rate, but you also benefit when prices fall. And in a market that has been oversupplied for two years, with European prices down 15% year-on-year before this shock 3, prices will likely moderate once the immediate disruption eases.
The difference between these two options over a twelve-month cycle, assuming the disruption lasts three to six months before moderating, is significant. The company that locked in an indexing mechanism in the first week pays a transparent, market-linked price. The company that waited for the letter pays a ratcheted price that rarely comes back down at the same speed it went up.
That delta, for a company of this size, is measured in hundreds of thousands of euros per year.
Why this decision did not get made
This is not an information problem. Every procurement team in Europe knows that PP prices have spiked. The Platts data is published 1. The freight disruption is in the news. The underlying cause is on the front page of every newspaper.
The problem is structural. There is no process in most organisations that takes a commodity price movement, traces it through the tier 2 supply chain to its impact on finished goods cost, identifies the available responses, quantifies the trade-offs, and forces a choice with a deadline.
Instead, what happens is a series of conversations. Procurement talks to finance. Finance asks for data. The data takes two weeks to compile because it sits across three systems. By the time the analysis is ready, the window for proactive renegotiation has closed. The price increase letter arrives. The conversation shifts from strategy to damage control.
The information existed at every point. What was missing was a structured decision process that connected the signal to the options to the cost of delay.
The gap we see
This pattern repeats. A commodity shock, a regulatory change, a supplier disruption. The data arrives early. The decision arrives late. The cost of that delay is measurable but rarely measured, because by the time anyone looks back, the new price is just the price.
We started building ChainAlign because we kept seeing this gap from the inside. Procurement teams with access to better data than at any point in history, still making critical decisions reactively because no system connected what they knew to what they needed to decide, and by when.
The problem is not analytics. The problem is not dashboards. The problem is the space between a signal appearing in the data and a structured set of options landing on the right desk with a clear cost of waiting. That space is where decisions go to die.
I do not know whether the polypropylene market will stabilise in Q3 or stay elevated through the year. Nobody does. What I do know is that the organisations that treated this as a decision to be made in the first week, not a cost to be absorbed in month three, will come out of this cycle in a fundamentally different position.
And that difference has nothing to do with having better data. It has everything to do with having a better process for turning data into a structured choice before the window closes.
Sources
- S&P Global Commodity Insights (Platts), "Polypropylene prices rise globally following outbreak of Middle East war," 13 March 2026. PP homopolymer injection-grade FD NWE spot assessed at EUR 1,200/mt, up EUR 220/mt since start of March.
- Polymerupdate, "European Polypropylene (PP) prices surge sharply amid disrupted trade flows and rising production costs," March 2026. European propylene contract price for March 2026 settled at EUR 1,000/mt FD NWE; propylene spot assessed at EUR 1,130–1,140/mt, up EUR 200/mt week-on-week.
- IMARC Group, "Polypropylene Prices March 2026." European PP prices registered a 4.5% decline between September and December 2025, with year-on-year decreases reflecting dampened consumption from packaging, automotive, and injection moulding sectors.
- ChemOrbis, "European PP market shifts focus to March amid easing import pressure and cautious demand recovery," March 2026. February gains were limited largely in line with the EUR 15/ton propylene settlement.
- PlasticPortal.eu, "Polymer prices — before the price increase in March," 26 February 2026. Pre-conflict analysis noting the free passage of the Strait of Hormuz was already questionable due to the unfolding conflict with Iran.